[Pharmacologic studies with trophosphamide (Ixoten), a new oxazaphosphorineoxide].
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D055598:Chemical Phenomena; D002621:Chemistry; D003498:Cyclic P-Oxides / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D004285:Dogs; D005260:Female; D006168:Guinea Pigs; D007928:Lethal Dose 50; D051379:Mice; D009588:Nitrogen Mustard Compounds / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D010078:Oxazines / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D011817:Rabbits; D051381:Rats; D012517:Sarcoma, Yoshida / Q000188:drug therapy*; D013329:Structure-Activity Relationship
D000970:Antineoplastic Agents; D003498:Cyclic P-Oxides; D009588:Nitrogen Mustard Compounds; D010078:Oxazines
Pharmakolgische Untersuchungen mit Trofosfamid (Ixoten), einem neuen Oxazaphosphorinoxid.